Exosome RNA Exosome RNA Research & Industry News
Mursla, a liquid biopsy company, has raised £410K from the UK Government’s Future Fund and existing investors. In addition, the organisation has secured a £40K COVID-19 grant from the Cambridgeshire Capital Grant Scheme. The funding will enable Mursla to finalise ...
Read More »Mursla raises £0.5M funding to progress development of its exosome-based novel technology platform for cancer detection
